Hims & Hers surges after RFK Jr. tells Joe Rogan he’s hoping to make peptides more accessible
Hims & Hers is spiking on Monday amid some remarks that Health and Human Services Secretary Robert F. Kennedy Jr. made on the “Joe Rogan Experience” podcast.
At around the 1.5-hour mark of the podcast, RFK Jr. indicated that he’s “very anxious” to make about 14 peptides more accessible (and allow for compounding), and that the FDA is currently “looking at the science” of these treatments.
“My hope is that they’re going to get moved to a place where people have access from ethical suppliers,” he said.
A more permissive stance toward these peptides — short chains of amino acids that regulate a variety of processes in the body and are the active ingredient in popular GLP-1 medications used to treat diabetes and weight loss — would potentially open up substantial new revenue opportunities for Hims.
As for why the stock didn’t react more on Friday, well, that’s a bit of a noodle-scratcher. But this episode was released at 1 p.m. ET, and may not have had enough time to be fully digested and disseminated before the weekend.
The legal and regulatory apparatuses have been a big headwind for Hims in 2026, but perhaps these remarks (and the reaction) are a signal that these winds might be starting to shift.